All Stories

  1. Biomarkers for advancing diagnosis and prognosis in stroke
  2. Dissecting Aneurysm in Cervical Artery Dissection: Insights From the STOP-CAD Study
  3. Recurrent Cervical Artery Dissection Prevalence and Predictors: A Secondary Analysis of the STOP-CAD Study
  4. Preceding Infections and Coagulation Biomarkers in Early-Onset Cryptogenic Ischemic Stroke
  5. Thrombophilia Screening in Young Patients With Cryptogenic Ischemic Stroke
  6. Family history of stroke and cardiovascular diseases in early-onset cryptogenic ischaemic stroke
  7. Cervical Artery Dissection Diagnosed Following Chiropractic Cervical Manipulation
  8. Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke
  9. Stroke Action Plan for Europe 2018–2030 (SAP-E): mid-term review and update
  10. Effect of colchicine for secondary prevention according to stroke subtype: A secondary analysis of the CONVINCE randomized trial
  11. Fibromuscular Dysplasia and Spontaneous Cervical Artery Dissection
  12. Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage
  13. Unrecognized Myocardial Fibrosis Detected by Contrast-Enhanced Cardiovascular MRI in Patients With Ischemic Stroke
  14. Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke
  15. Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale
  16. Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection
  17. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  18. Association Between Self-Perceived Stress and Cryptogenic Ischemic Stroke in Young Adults
  19. Association of Smoking and Young Cryptogenic Ischemic Stroke
  20. Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
  21. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  22. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial
  23. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  24. Stroke and Recent Myocardial Infarction, Reduced Left Ventricular Ejection Fraction, Left Ventricular Thrombus, and Wall Motion Abnormalities
  25. Deep Learning-Based Extraction of Biomarkers for the Prediction of the Functional Outcome of Ischemic Stroke Patients
  26. Neglect scoring modifications in the National Institutes of Health Stroke Scale improve right hemisphere stroke lesion volume prediction
  27. Sensitivity and Accuracy of Doppler Ultrasound compared to CT Angiography for the Diagnosis of Carotid Webs: Systematic Review
  28. Diagnosis of atrial fibrillation in young patients with ischemic stroke: A systematic review and meta-analysis
  29. Ultrasonographic Vasospasm and Outcome of Posterior Reversible Encephalopathy and Cerebral Vasoconstriction Syndromes
  30. Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke
  31. Update on Biomarkers Associated with Large Artery Atherosclerosis Stroke
  32. Gout Flare and Cardiovascular Events
  33. Follow-Up by Transcranial Doppler After Rupture of a Giant Intracranial Aneurysm
  34. Clinical presentation and neural correlates of stroke‐associated spatial delusions
  35. Leaving no stone unturned: the search for stroke associated with atrial fibrillation
  36. Time perception changes in stroke patients: A systematic literature review
  37. Organizational Update: World Stroke Conference 2021
  38. Obesity and the Risk of Cryptogenic Ischemic Stroke in Young Adults
  39. How Can Biobanks Help You in Your Research Projects?
  40. Incorporating Quality Improvement Projects Into Stroke Care and Research
  41. EXPRESS: European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stro...
  42. European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anter...
  43. Acute Myocardial Infarction after Intravenous Thrombolysis for Acute Ischemic Stroke: Case Series and Systematic Review
  44. From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
  45. Mapping delusions of space onto a structural disconnectome that decouples familiarity and place networks
  46. Uncertainties and Controversies in the Management of Ischemic Stroke and Transient Ischemic Attack Patients With Patent Foramen Ovale
  47. Cerebrovascular Complications of Anemia
  48. The dawn of precision medicine in stroke
  49. Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis
  50. Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial
  51. Mean Platelet Volume is a Prognostic Marker in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
  52. Update on Biomarkers Associated to Cardioembolic Stroke: A Narrative Review
  53. Undergraduate neurology teaching: Comparison of an inpatient versus outpatient clinical setting
  54. Unravelling the Neural Basis of Spatial Delusions After Stroke
  55. European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack
  56. European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
  57. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
  58. Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
  59. An image is not always worth a thousand words: an image mimic of transient global amnesia
  60. Cardiovascular magnetic resonance imaging and its role in the investigation of stroke: an update
  61. Neurological complications of cardiomyopathies
  62. Precision Medicine in Stroke
  63. Undergraduate neurology teaching: comparison of an inpatient versus outpatient clinical setting.
  64. Author response: Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance
  65. Association between migraine and cryptogenic ischemic stroke in young adults
  66. Transient Ischemic Attack
  67. Value of Treatment by Comprehensive Stroke Services for the reduction of critical gaps in acute stroke care in Europe
  68. Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance
  69. Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction
  70. Neurological Complications of Infective Endocarditis
  71. Chronic headache with vasospasm treated with nimodipine
  72. Neurological Complications of Cardiac Tumors
  73. Etiologic Evaluation of Ischemic Stroke in Young Adults: A Comparative Study between Two European Centers
  74. Women Who Have Ischemic Strokes Have a Higher Burden of Left Atrial Fibrosis Than Men
  75. Quantitative EEG and functional outcome following acute ischemic stroke
  76. Memory impairment due to bilateral fornix infarction: Characterisation and follow-up
  77. Patent foramen ovale and stroke
  78. Early EEG predicts poststroke epilepsy
  79. Patients With Undetermined Stroke Have Increased Atrial Fibrosis
  80. European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke
  81. Voluntary control of a plegic limb during yawning
  82. Using Machine Learning to Improve the Prediction of Functional Outcome in Ischemic Stroke Patients
  83. Bilateral parotid gland hemorrhage after intravenous thrombolysis for stroke treatment
  84. Seizures, electroencephalographic abnormalities, and outcome of ischemic stroke patients
  85. Post-stroke seizures are clinically underestimated
  86. Epilepsia partialis continua after an anterior circulation ischaemic stroke
  87. Epileptic manifestations in stroke patients treated with intravenous alteplase
  88. Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design
  89. The Changing Landscape for Stroke Prevention in AF
  90. Increase in the Admission of Stroke Mimics after Change in Emergency Shifts
  91. An unsuspected cause of hypnic-like headache
  92. Laterality of Pneumonia in Acute Stroke
  93. Loss of object ownership feeling following a left hemisphere infarct
  94. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
  95. Language improvement one week after thrombolysis in acute stroke
  96. Recurrent cerebral ischaemic events in the setting of paroxysmal nocturnal haemoglobinuria
  97. Subarachnoid Haemorrhage and Sports
  98. Brain Magnetic Resonance with Negative Diffusion-Weighted Imaging: Does It Preclude Acute Stroke Diagnosis?
  99. Axial myoclonus after ischemic stroke
  100. Short-term outcome of patients with possible transient ischemic attacks: a prospective study
  101. B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis
  102. Cryptogenic stroke
  103. Ischemic Stroke
  104. Stroke: an update
  105. Infective endocarditis
  106. Nontraumatic Convexity Subarachnoid Hemorrhage: Different Etiologies and Outcomes
  107. N-Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients
  108. Cotard delusion after stroke
  109. Time course of NT-proBNP levels after acute ischemic stroke
  110. Drug Abuse and Stroke
  111. Does Anticoagulation Promote Mural Hematoma Growth or Delayed Occlusion in Spontaneous Cervical Artery Dissections
  112. Snoring and Severity of Symptomatic and Asymptomatic Carotid Stenosis: A Population-Based Study
  113. Why did we perform a lumbar puncture in a young patient with ischemic stroke?
  114. Improvement of sleep architecture in the follow up of a patient with bilateral paramedian thalamic stroke
  115. Treatment with rtPA of stroke associated with intravenous immunoglobulins perfusion
  116. N-Terminal Probrain Natriuretic Peptide as a Biomarker of Cardioembolic Stroke
  117. Diagnostic difficulties in the classification of transient neurological attacks
  118. Neck Hematoma after Intravenous Thrombolysis for Stroke Treatment
  119. Influence of climatic factors in the incidence of multiple sclerosis relapses in a Portuguese population
  120. Reversible bilateral sensorineural hearing loss in a woman with cerebral venous thrombosis
  121. Sneeze as a precipitating factor of cerebral venous thrombosis